Cite
HARVARD Citation
Kupczyk, M. et al. (2021). A new formulation of fluticasone propionate/salmeterol in a metered-dose inhaler (MDI HFA) allows for the reduction of a daily dose of corticosteroid and provides optimal asthma control - A randomized, multi-center, non-inferiority, phase IV clinical study. Respiratory medicine. p. . [Online].